The Business Research Company’s Microbiome Market 2022 – Opportunities And Strategies – Global Forecast To 2031
LONDON, GREATER LONDON, UK, July 21, 2022 /EINPresswire.com/ -- The increasing use of artificial intelligence (AI) is a key trend gaining popularity in the microbiome market. Artificial intelligence is computer intelligence or intelligence demonstrated by a machine to help perform simple tasks or tasks that couldn’t be performed otherwise. AI helps in various applications such as for colorectal cancer, and the ever-increasing amounts of microbiome data combined with other high-quality clinical and imaging datasets are leading the study of gastrointestinal diseases into an era of biomedical big data. Technologies such as “omics” make use of machine learning or AI for microbiome analysis; machine learning is key to extracting relevant information from microbiome data as one of the biggest challenges of microbiome analysis includes noisy, sparse, and high dimensional datasets, with many more microbial features than samples, with AI tools helping to smooth the analysis. According to the microbiome market analysis, AI technology has also been used to investigate the association with certain conditions/diseases.The global microbiome market size is expected to grow from $340.80 million in 2021 to $945.10 million in 2026 at a rate of 22.6%. The global microbiome market share is then expected to grow at a CAGR of 15.4% from 2026 and reach $1,932.50 million in 2031.
Read more on the Global Microbiome Market Report
https://www.thebusinessresearchcompany.com/report/microbiome-market
Increasing healthcare expenditure is predicted to upsurge the microbiome industry growth. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical and clinical services, thereby driving the market. According to the National Health Expenditure Projections 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Furthermore, prescription drug spending is projected to grow by 6.1% annually during 2020-2027. According to the microbiome market overview, the rise in healthcare spending will increase the market for microbiomes in the near future.
Major players covered in the global microbiome industry are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc.
TBRC’s microbiome market report is segmented by type into bacteria, archaea, viruses, other microbiomes, by product into therapeutics, diagnostics.
Microbiome Market 2022 – By Type (Bacteria, Archaea, Viruses, Other Microbiomes), By Product (Therapeutics, Diagnostics), By Microbiome Therapeutic (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Others), By Microbiome Diagnostic (Genomics, Proteomics, Metabolomics), By End-Use (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases), By Technology (Genomics, Proteomics, Metabolomics), And By Region, Opportunities And Strategies – Global Forecast To 2031 is one of a series of new reports from The Business Research Company that provides a microbiome market overview, forecast microbiome market size and growth for the whole market, microbiome market segments, geographies, microbiome market trends, microbiome market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request for a Sample of the Global Microbiome Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=4064&type=smp
Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Bioinformatics Global Market Report 2022 – By Products and Services (Knowledge Management Tools, Data Analysis Platforms, Services), By Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatics, Genomics), By End Users (Pharmaceutics, Animal Study, Agriculture, Forensic Science, Other End Users) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report
Human Microbiome Therapeutics Market - By Disease (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers), By Sequencing Technology Type (Targeted Gene, RNA, Whole-Genome Shotgun (WGS)) And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/human-microbiome-therapeutics-market
Genomics Global Market Report 2022 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
About The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn